Therapeutic pipeline in nonalcoholic steatohepatitis

Volume: 18, Issue: 6, Pages: 373 - 392
Published: Feb 10, 2021
Abstract
Our understanding of nonalcoholic fatty liver disease pathophysiology continues to advance rapidly. Accordingly, the field has moved from describing the clinical phenotype through the presence of nonalcoholic steatohepatitis (NASH) and degree of fibrosis to deep phenotyping with a description of associated comorbidities, genetic polymorphisms and environmental influences that could be associated with disease progression. These insights have...
Paper Details
Title
Therapeutic pipeline in nonalcoholic steatohepatitis
Published Date
Feb 10, 2021
Volume
18
Issue
6
Pages
373 - 392
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.